Overall rank by patents
#28,966
of 49,997 tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).
The verdict
According to USPTO PatentsView, Hero ranks #28,966 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R28966 · Foreign Corporation #28,966 · 9 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Hefei CAS ION Medical AND Technical Devices Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Donnelly · near
51 score
Hero Scientific · this assignee
51 score
Intercontinental… · near
51 score
Sungkyunkwan… · near
51 score
UNIVERSITÉ Paris… · near
51 score
3D Lighting… · lowest
7 score
What this shows Hero's Innovation Score is 50.9/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Hero Scientific Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 66.7% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2024 (6 grants) versus a trough of 2 in 2023. By volume, Hero sits between Hefei CAS ION Medical AND Technical Devices Co., Ltd. and HG Partners, LLC.
Hero Scientific Ltd. shows 8 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Hefei CAS ION Medical AND Technical Devices Co., Ltd.
9 patents
Hemlock Semiconductor Operations LLC
9 patents
Hengdian Group Innuovo Electric Co., Ltd.
9 patents
Hero Health Inc.
9 patents
Heron Neutron Medical Corp.
9 patents
Hexagon Geosystems Services AG
9 patents
Heys International Ltd.
9 patents
HG Partners, LLC
9 patents
Hero Scientific Ltd.
9 patents
What this shows Hero holds 9 patents at rank #28,931, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #28,931 in granted patent volume.
Other assignees with the most granted patents in Hero's primary technology class.
Two PlainPatent-derived peer sets for Hero, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (51 here).
Hero's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 2 | 22.2% |
| 2024 | 6 | 66.7% |
| 2025partial year | 1 | 11.1% |
Top 5 of 5 technology areas
Overall rank by patents
#28,966
of 49,997 tracked assignees
50.9 out of 100
What to do with this data
Hero Scientific Ltd.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.